vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Worksport Ltd (WKSP). Click either name above to swap in a different company.

Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $4.7M, roughly 1.9× Worksport Ltd). On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 62.0%). Over the past eight quarters, Worksport Ltd's revenue compounded faster (204.2% CAGR vs 35.3%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

Worksport Ltd is a cleantech company specializing in portable solar energy solutions and custom truck bed accessories. Its core offerings include solar-powered tonneau covers for pickup trucks and portable mobile power stations, serving the North American automotive aftermarket and consumer clean energy segments.

FHTX vs WKSP — Head-to-Head

Bigger by revenue
FHTX
FHTX
1.9× larger
FHTX
$9.2M
$4.7M
WKSP
Growing faster (revenue YoY)
FHTX
FHTX
+161.8% gap
FHTX
223.8%
62.0%
WKSP
Faster 2-yr revenue CAGR
WKSP
WKSP
Annualised
WKSP
204.2%
35.3%
FHTX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FHTX
FHTX
WKSP
WKSP
Revenue
$9.2M
$4.7M
Net Profit
$-21.7M
Gross Margin
30.1%
Operating Margin
-258.2%
-129.6%
Net Margin
-234.3%
Revenue YoY
223.8%
62.0%
Net Profit YoY
-11.1%
EPS (diluted)
$-0.35
$-0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
WKSP
WKSP
Q4 25
$9.2M
$4.7M
Q3 25
$8.2M
$5.0M
Q2 25
$7.6M
$4.1M
Q1 25
$6.0M
$2.2M
Q4 24
$2.9M
$2.9M
Q3 24
$7.8M
$3.1M
Q2 24
$6.9M
$1.9M
Q1 24
$5.0M
$512.6K
Net Profit
FHTX
FHTX
WKSP
WKSP
Q4 25
$-21.7M
Q3 25
$-15.8M
$-4.9M
Q2 25
$-17.9M
$-3.7M
Q1 25
$-18.8M
$-4.5M
Q4 24
$-19.5M
Q3 24
$-19.1M
$-4.1M
Q2 24
$-23.0M
$-4.0M
Q1 24
$-25.0M
$-3.7M
Gross Margin
FHTX
FHTX
WKSP
WKSP
Q4 25
30.1%
Q3 25
31.3%
Q2 25
26.4%
Q1 25
17.7%
Q4 24
11.1%
Q3 24
7.9%
Q2 24
15.4%
Q1 24
7.3%
Operating Margin
FHTX
FHTX
WKSP
WKSP
Q4 25
-258.2%
-129.6%
Q3 25
-226.9%
-95.6%
Q2 25
-279.2%
-88.1%
Q1 25
-385.0%
-190.0%
Q4 24
-840.5%
-137.0%
Q3 24
-305.5%
-125.1%
Q2 24
-386.6%
-203.5%
Q1 24
-558.3%
-709.9%
Net Margin
FHTX
FHTX
WKSP
WKSP
Q4 25
-234.3%
Q3 25
-194.4%
-98.3%
Q2 25
-237.3%
-91.0%
Q1 25
-316.4%
-199.1%
Q4 24
-682.9%
Q3 24
-244.9%
-132.4%
Q2 24
-333.6%
-208.9%
Q1 24
-495.4%
-724.6%
EPS (diluted)
FHTX
FHTX
WKSP
WKSP
Q4 25
$-0.35
$-0.65
Q3 25
$-0.25
$-0.75
Q2 25
$-0.28
$-0.71
Q1 25
$-0.30
$-1.05
Q4 24
$-0.23
$-1.14
Q3 24
$-0.31
$-1.40
Q2 24
$-0.45
$-1.55
Q1 24
$-0.59
$-1.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
WKSP
WKSP
Cash + ST InvestmentsLiquidity on hand
$80.9M
$5.9M
Total DebtLower is stronger
$2.7M
Stockholders' EquityBook value
$-108.5M
$22.9M
Total Assets
$198.1M
$30.7M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
WKSP
WKSP
Q4 25
$80.9M
$5.9M
Q3 25
$89.3M
$3.8M
Q2 25
$72.6M
$1.4M
Q1 25
$61.0M
$5.1M
Q4 24
$55.5M
$4.9M
Q3 24
$57.7M
$1.9M
Q2 24
$138.9M
$3.4M
Q1 24
$79.3M
$3.5M
Total Debt
FHTX
FHTX
WKSP
WKSP
Q4 25
$2.7M
Q3 25
$2.9M
Q2 25
$2.5M
Q1 25
$3.1M
Q4 24
$5.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FHTX
FHTX
WKSP
WKSP
Q4 25
$-108.5M
$22.9M
Q3 25
$-89.7M
$19.8M
Q2 25
$-76.7M
$17.3M
Q1 25
$-61.7M
$20.1M
Q4 24
$-45.5M
$17.4M
Q3 24
$-28.3M
$16.4M
Q2 24
$-14.3M
$19.1M
Q1 24
$-97.5M
$18.9M
Total Assets
FHTX
FHTX
WKSP
WKSP
Q4 25
$198.1M
$30.7M
Q3 25
$205.0M
$27.0M
Q2 25
$226.2M
$23.6M
Q1 25
$258.7M
$26.7M
Q4 24
$284.0M
$25.7M
Q3 24
$308.4M
$24.9M
Q2 24
$328.6M
$27.2M
Q1 24
$255.0M
$27.3M
Debt / Equity
FHTX
FHTX
WKSP
WKSP
Q4 25
0.12×
Q3 25
0.15×
Q2 25
0.14×
Q1 25
0.16×
Q4 24
0.30×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
WKSP
WKSP
Operating Cash FlowLast quarter
$-22.3M
$-6.1M
Free Cash FlowOCF − Capex
$-6.3M
FCF MarginFCF / Revenue
-132.4%
Capex IntensityCapex / Revenue
0.0%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-18.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
WKSP
WKSP
Q4 25
$-22.3M
$-6.1M
Q3 25
$-18.9M
$-4.3M
Q2 25
$-21.0M
$-3.1M
Q1 25
$-24.0M
$-3.8M
Q4 24
$-24.5M
$-2.2M
Q3 24
$-21.0M
$-1.5M
Q2 24
$-25.5M
$-3.6M
Q1 24
$-29.3M
$-2.8M
Free Cash Flow
FHTX
FHTX
WKSP
WKSP
Q4 25
$-6.3M
Q3 25
$-4.6M
Q2 25
$-21.0M
$-3.2M
Q1 25
$-24.0M
$-4.0M
Q4 24
$-25.0M
$-2.2M
Q3 24
$-21.3M
$-1.7M
Q2 24
$-25.6M
$-3.7M
Q1 24
$-29.4M
$-3.0M
FCF Margin
FHTX
FHTX
WKSP
WKSP
Q4 25
-132.4%
Q3 25
-92.1%
Q2 25
-278.2%
-77.1%
Q1 25
-403.2%
-180.4%
Q4 24
-875.3%
-75.4%
Q3 24
-273.0%
-54.5%
Q2 24
-371.0%
-195.1%
Q1 24
-583.1%
-586.7%
Capex Intensity
FHTX
FHTX
WKSP
WKSP
Q4 25
0.0%
3.3%
Q3 25
0.0%
7.3%
Q2 25
0.3%
1.7%
Q1 25
0.5%
9.0%
Q4 24
16.8%
0.9%
Q3 24
4.0%
5.3%
Q2 24
0.2%
6.4%
Q1 24
2.0%
41.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons